Département Universitaire de Médecine Générale - Université Toulouse III Paul Sabatier, 133 Route de Narbonne, 31062, Toulouse Cedex, France.
Faculté de médecine, CERPOP - UMR 1295 INSERM - Université Toulouse III Paul Sabatier, 37 allées Jules Guesde -, 31000, Toulouse, France.
BMC Prim Care. 2022 Nov 17;23(1):283. doi: 10.1186/s12875-022-01891-9.
To promote improved coordination between general practice and hospital, the French clinical trial CREDO ("Concertation de REtour à DOmicile") is testing an innovative experimental consultation for patients with metastatic cancer who are returning home. This consultation involves the patient, the patient's referring GP (GP) and a GP with specific skills in oncology (GP) in a specialized care center. The objective of our study is to explore the satisfaction of GPs about this consultation, in the phase of interaction between GP and GP.
This observational, cross-sectional, multicenter study explored the satisfaction of GPs who had participated in this type of consultation, via a telephone survey.
One Hundred GPs responded to the questionnaire between April and September 2019 (overall response rate: 55%). 84.5% were satisfied with the consultation, and the majority were satisfied with its methods. Half of the GPs learned new information during the consultation, three-quarters noted an impact on their practice, and 94.4% thought that this type of coordination between the GP and the oncology specialist could improve general practice - hospital coordination.
For GPs, the CREDO consultation seems to be practical and effective in improving the coordination between general medicine and hospital. GPs would benefit from such coordination for all patients with cancer, several times during follow-up and at each occurrence of a medically significant event.
为了促进全科医学与医院之间更好的协调，法国临床试验 CREDO（“回归家庭的协调”）正在测试一种针对转移性癌症患者的创新实验性咨询，这些患者正在返回家中。该咨询涉及患者、患者的转诊全科医生（GP）和具有肿瘤学专业技能的 GP ，在专门的护理中心进行。我们的研究目的是探讨 GP 对这种咨询的满意度，即 GP 与 GP 之间的互动阶段。
这项观察性、横断面、多中心研究通过电话调查探讨了参与这种咨询的 GP 的满意度。
2019 年 4 月至 9 月期间，有 100 名 GP 回应了问卷（总体回应率：55%）。84.5%的 GP 对咨询感到满意，大多数对咨询方法感到满意。半数 GP 在咨询中获得了新信息，四分之三的 GP 注意到对其实践的影响，94.4%的 GP 认为这种 GP 与肿瘤专家之间的协调可以改善全科医学-医院之间的协调。
对于 GP 来说，CREDO 咨询似乎在改善全科医学与医院之间的协调方面具有实用性和有效性。对于所有癌症患者，GP 都将从这种协调中受益，在随访期间多次发生，并且在每次发生有医学意义的事件时都能受益。
